Serotonin Uptake Inhibitors
"Serotonin Uptake Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that specifically inhibit the reuptake of serotonin in the brain.
| Descriptor ID |
D017367
|
| MeSH Number(s) |
D27.505.519.562.437.850 D27.505.519.625.600.850 D27.505.519.625.850.900 D27.505.696.577.600.850 D27.505.696.577.850.900
|
| Concept/Terms |
Serotonin Uptake Inhibitors- Serotonin Uptake Inhibitors
- 5-Hydroxytryptamine Uptake Inhibitors
- 5 Hydroxytryptamine Uptake Inhibitors
- Inhibitors, 5-HT Uptake
- Inhibitors, 5 HT Uptake
- Inhibitors, 5-Hydroxytryptamine Uptake
- Inhibitors, 5 Hydroxytryptamine Uptake
- Inhibitors, Serotonin Reuptake
- Reuptake Inhibitors, Serotonin
- Serotonin Reuptake Inhibitors
- Uptake Inhibitors, 5-HT
- Uptake Inhibitors, 5 HT
- Uptake Inhibitors, 5-Hydroxytryptamine
- Uptake Inhibitors, 5 Hydroxytryptamine
- Uptake Inhibitors, Serotonin
- 5-HT Uptake Inhibitors
- 5 HT Uptake Inhibitors
- Inhibitors, Serotonin Uptake
|
Below are MeSH descriptors whose meaning is more general than "Serotonin Uptake Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Serotonin Uptake Inhibitors".
This graph shows the total number of publications written about "Serotonin Uptake Inhibitors" by people in this website by year, and whether "Serotonin Uptake Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 4 | 4 | 8 |
| 2010 | 0 | 1 | 1 |
| 2011 | 8 | 1 | 9 |
| 2012 | 3 | 1 | 4 |
| 2013 | 4 | 0 | 4 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serotonin Uptake Inhibitors" by people in Profiles.
-
Can the Risk of Severe Depression-Related Outcomes Be Reduced by Tailoring the Antidepressant Therapy to Patient Characteristics? Am J Epidemiol. 2021 07 01; 190(7):1210-1219.
-
Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders. Biol Psychiatry. 2021 08 15; 90(4):253-262.
-
Screening for Anxiety in Adolescent and Adult Women: A Recommendation From the Women's Preventive Services Initiative. Ann Intern Med. 2020 07 07; 173(1):48-56.
-
Augmenting usual care SSRIs with cognitive behavioral therapy for insomnia to improve depression outcomes in youth: Design of a randomized controlled efficacy-effectiveness trial. Contemp Clin Trials. 2020 04; 91:105967.
-
Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding. Ann Epidemiol. 2019 07; 35:42-47.e1.
-
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstet Gynecol. 2015 Aug; 126(2):413-22.
-
COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL. Depress Anxiety. 2015 Aug; 32(8):570-9.
-
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause. 2015 Jun; 22(6):607-15.
-
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med. 2014 Jul; 174(7):1058-66.
-
Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. Am J Cardiol. 2014 Aug 15; 114(4):583-6.